Heat Biologics EPS - Earnings per Share 2013-2019 | HTBX

Heat Biologics eps - earnings per share from 2013 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Heat Biologics Annual EPS
2018 $-0.90
2017 $-3.08
2016 $-7.15
2015 $-25.30
2014 $-18.30
2013 $-24.20
2012 $-13.20
2011 $-3.60
Heat Biologics Quarterly EPS
Q3 2019 $-0.18
Q2 2019 $-0.14
Q1 2019 $-0.17
Q4 2018 $0.23
Q3 2018 $-0.16
Q2 2018 $-0.26
Q1 2018 $-0.71
Q4 2017 $-0.35
Q3 2017 $-0.64
Q2 2017 $-0.91
Q1 2017 $-1.18
Q4 2016 $0.35
Q3 2016 $-0.80
Q2 2016 $-1.70
Q1 2016 $-5.00
Q4 2015 $-7.80
Q3 2015 $-6.20
Q2 2015 $-5.60
Q1 2015 $-5.70
Q4 2014 $-5.70
Q3 2014 $-4.60
Q2 2014 $-4.40
Q1 2014 $-3.60
Q4 2013 $6.40
Q3 2013 $-4.80
Q2 2013 $-9.20
Q1 2013 $-16.60
Q4 2012 $-5.50
Q3 2012 $-3.10
Q2 2012 $-3.80
Q1 2012 $-0.80
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.015B $0.006B
Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.496B 10.03
Zoetis (ZTS) United States $56.165B 33.60
Astellas Pharma (ALPMY) Japan $31.345B 15.66
Eisai (ESALY) Japan $18.870B 36.39
Merck (MKGAF) Germany $15.276B 20.85
Grifols, S.A (GRFS) Spain $14.913B 19.03
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.411B 491.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.244B 16.70
Jazz Pharmaceuticals (JAZZ) Ireland $7.843B 10.02
Sage Therapeutics (SAGE) United States $7.582B 0.00
Catalent (CTLT) United States $7.377B 30.01
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.134B 18.45
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 103.13
United Therapeutics (UTHR) United States $3.968B 0.00
Nektar Therapeutics (NKTR) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.363B 12.29
FibroGen (FGEN) United States $3.227B 94.85
Evotec AG (EVTCY) Germany $3.081B 50.42
PTC Therapeutics (PTCT) United States $2.693B 0.00
Portola Pharmaceuticals (PTLA) United States $2.117B 0.00
Xencor (XNCR) United States $2.041B 62.03
Tilray (TLRY) Canada $1.998B 0.00
Zogenix (ZGNX) United States $1.998B 0.00
Heron Therapeutics (HRTX) United States $1.943B 0.00
Corcept Therapeutics (CORT) United States $1.879B 22.83
Ironwood Pharmaceuticals (IRWD) United States $1.800B 57.40
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.560B 16.65
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.232B 20.33
Radius Health (RDUS) United States $1.108B 0.00
Endo (ENDP) Ireland $1.027B 1.89
Theravance Biopharma (TBPH) Cayman Islands $1.013B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
ArQule (ARQL) United States $0.951B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.938B 0.00
Aerie Pharmaceuticals (AERI) United States $0.877B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.823B 5.61
Organogenesis Holdings (ORGO) United States $0.758B 0.00
TherapeuticsMD (TXMD) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Collegium Pharmaceutical (COLL) United States $0.607B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ChemoCentryx (CCXI) United States $0.513B 0.00
ImmunoGen (IMGN) United States $0.495B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 55.50
Crinetics Pharmaceuticals (CRNX) United States $0.450B 0.00
OptiNose (OPTN) United States $0.433B 0.00
Dermira (DERM) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.402B 9.19
Akebia Therapeutics (AKBA) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.78
Recro Pharma (REPH) United States $0.389B 0.00
Indivior (INVVY) United States $0.387B 1.40
Ardelyx (ARDX) United States $0.386B 0.00
DURECT (DRRX) United States $0.373B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.29
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.288B 0.00
GlycoMimetics (GLYC) United States $0.270B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
Rafael Holdings (RFL) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.222B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.37
Calithera Biosciences (CALA) United States $0.188B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
Jounce Therapeutics (JNCE) United States $0.174B 2.33
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.134B 0.00
CV Sciences (CVSI) United States $0.134B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.131B 0.00
IMV INC (IMV) Canada $0.126B 0.00
CannTrust Holdings (CTST) Canada $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.092B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 22.05
Generex Biotechnology (GNBT) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Natural Alternatives (NAII) United States $0.061B 15.18
Genocea Biosciences (GNCA) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Novan (NOVN) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Capnia (SLNO) United States $0.049B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Mast Therapeutics (SVRA) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00